Cephradine USP 250mg Capsule.
In the treatment of infections of the urinary, respiratory and gastrointestinal tracts and of the skin and soft tissues. These include : Upper respiratory tract infections : pharyngitis, sinusitis, otitis media, tonsillitis, laryngo-tracheo bronchitis. Lower respiratory tract infections : acute and chronic bronchitis, lobar and bronchopneumonia. Urinary tract infections : cystitis, urethritis, pyelonephritis. Skin and soft tissue infections : abscess, cellulitis, furunculosis, impetigo. Gastro-intestinal tract : bacillary dysentery, enteritis, peritonitis.
Cephradine USP 250mg Capsule.
In the treatment of infections of the urinary, respiratory and gastrointestinal tracts and of the skin and soft tissues. These include : Upper respiratory tract infections : pharyngitis, sinusitis, otitis media, tonsillitis, laryngo-tracheo bronchitis. Lower respiratory tract infections : acute and chronic bronchitis, lobar and bronchopneumonia. Urinary tract infections : cystitis, urethritis, pyelonephritis. Skin and soft tissue infections : abscess, cellulitis, furunculosis, impetigo. Gastro-intestinal tract : bacillary dysentery, enteritis, peritonitis.
Drug International Limited was incorporated under the Registrar of Joint Stock Companies in 1974 as a Private Limited Company. The company commenced formulation and production in 1983 and emerged as a pioneer in Bangladesh for adding a state of the art oral solid dosage plant. Since inception, Drug International Limited's primary objective has been to meet guidelines provided by major global regulatory bodies such as the World Health Organization Good Manufacturing Practices (WHO cGMP) guidelines.